Curis | CRIS - Actif À Court Terme





Actif À Court Terme Changement Date
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
CSL USD 11.85B 1000K 2025-12
Curis USD 6.92M 7.5M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Merck USD 35.02B 8.5B 2026-03
Novartis USD 26.61B 3.85B 2026-03
Pfizer USD 42.82B 76M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Takeda JPY 3.09T 25.94B 2026-03
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12
Xoma USD 110.71M 5.78M 2025-09